BNT162b2 Versus mRNA‐1273 Vaccines: Comparative Analysis of Long‐Term Protection Against SARS‐CoV‐2 Infection and Severe COVID‐19 in Qatar

<h3>Background</h3><p dir="ltr">This study provides a head‐to‐head comparison of the protection provided by the BNT162b2 and mRNA‐1273 vaccines against SARS‐CoV‐2 infection and against severe COVID‐19, covering primary series and third dose/booster vaccinations over up to...

وصف كامل

محفوظ في:

التفاصيل البيبلوغرافية
المؤلف الرئيسي:	Hiam Chemaitelly (439114) (author)
مؤلفون آخرون:	Houssein H. Ayoub (22045208) (author), Peter Coyle (787159) (author), Patrick Tang (239534) (author), Mohammad R. Hasan (22045211) (author), Hadi M. Yassine (21841868) (author), Asmaa A. Al Thani (22045214) (author), Zaina Al‐Kanaani (17991526) (author), Einas Al‐Kuwari (14779336) (author), Andrew Jeremijenko (11506565) (author), Anvar Hassan Kaleeckal (22045217) (author), Ali Nizar Latif (22045220) (author), Riyazuddin Mohammad Shaik (22045223) (author), Hanan F. Abdul‐Rahim (22045226) (author), Gheyath K. Nasrallah (21841874) (author), Mohamed Ghaith Al‐Kuwari (22045229) (author), Adeel A. Butt (22045232) (author), Hamad Eid Al‐Romaihi (22045235) (author), Mohamed H. Al‐Thani (22045238) (author), Abdullatif Al‐Khal (14779372) (author), Roberto Bertollini (9538620) (author), Laith J. Abu‐Raddad (21841871) (author)
منشور في:	2024
الموضوعات:	Biomedical and clinical sciences Immunology Health sciences Epidemiology Public health cohort study COVID-19 epidemiology immune imprinting immunity vaccine
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

كن أول من يترك تعليقا!

BNT162b2 Versus mRNA‐1273 Vaccines: Comparative Analysis of Long‐Term Protection Against SARS‐CoV‐2 Infection and Severe COVID‐19 in Qatar

مواد مشابهة